Nutritional Status of Cancer Patients During the COVID-19 Pandemic
Medicina·
- DOI
- 10.3390/medicina62081584
- PMID
- —
- PMCID
- —
- OpenAlex
- W7203694799
- Study type
- Journal article
- Publisher
- MDPI AG
- Article type
- journal-article
- Integrity
- current
Why this research matters now
Identifying specific demographic and treatment-related markers of nutritional decline supports the development of focused monitoring protocols for vulnerable oncology populations during extended public health emergencies.
Structured evidence summary
Research question
The investigation seeks to determine whether oncology patients experienced shifts in nutritional vulnerability during a recent viral outbreak, utilizing a standardized screening tool to guide clinical monitoring strategies.
Study design
This represents a cross-sectional observational assessment conducted within a single academic medical center, where participants completed a validated nutritional risk questionnaire alongside demographic and clinical data collection.
Population and setting
The cohort comprised three hundred twenty-four individuals receiving care for various malignancies at a Turkish university hospital between late December 2021 and early January 2022.
Main findings
Elevated nutritional risk correlated with advanced disease staging, older age, male sex, and exposure to radiation therapy. Conversely, vaccination history and confirmed viral infection showed no meaningful statistical variation in risk scores. Although initial comparisons suggested delayed therapeutic interventions increased vulnerability, adjusted modeling demonstrated this factor lacked independent predictive value.
Public-health relevance
Identifying specific demographic and treatment-related markers of nutritional decline supports the development of focused monitoring protocols for vulnerable oncology populations during extended public health emergencies.
Important limitations
The cross-sectional framework prevents establishing temporal relationships between exposures and nutritional outcomes. Additionally, the absence of an independent link between treatment postponement and risk in adjusted models suggests potential confounding variables were not fully captured. Discrepancies regarding chemotherapy effects compared to established reports further indicate cohort-specific constraints.
GIDS interpretation
This publication contributes a region-specific snapshot of oncology care metrics during a defined pandemic window, offering contextual reference points for longitudinal tracking rather than real-time detection.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 9 auditable classifier relationships to diseases, places, topics, and study design.